Drugs / CPL-2009-0031
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04801199 | Jan 2020 → Jan 2021 | type 2 diabetes mellitus | Cadila Pharnmaceuticals | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CPL-2009-0031 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04801199 ↗ |
| Route | Oral | “Oral tablet containing 140 mg of CPL-2009-0031” NCT04801199 ↗ |